✦ LIBER ✦

Corrigendum to “Second line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study”

✍ Scribed by Camps, Carlos; Noguerón Martı́nez, Esther; Berrocal Jaime, Alfonso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line treatment with gemcitabine a

✍ Herrero, Carlos Camps; Noguerón Martı́nez, Esther; Jaime, Alfonso Berrocal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Cisplatin and vinorelbine as second-line

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Non-cisplatin-based chemotherapy for adv

✍ Rodríguez, R; Fírvada, JL; Mel, JR; Castellanos, J; Salgado, M; Mata, JG; Quinte 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Vinorelbine, ifosfamide and cisplatin (N

✍ Teixeira, E; Sotto-Mayor, R; Borges, M; Bugalho de Almeida, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Second-line treatment with single-agent

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB